Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China

Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, X · 2023

Read Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China by Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, X (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10719537.txt.

Description

Yanlin Li and a large team wrote a 2023 letter on COVID-19 outcomes in cancer patients on immune checkpoint drugs during China's Omicron wave. Data came from ten medical centers. The question was whether prior lung disease changes how such patients fare with the infection. These drugs act on immune brakes, a path that also matters in severe COVID-19, so concern about their joint effect runs high.

The team found that scarring lung disease and a collapsed lung state each tracked with worse outcomes. Those patients had more severe symptoms and needed more breathing support. Other lung conditions did not show the same link in their data. The authors call for closer watch over cancer patients with those two lung problems during infection. They note that low level Omicron spread may persist, so spotting high risk patients early stays important.

Catalog record

CREATORYanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, X
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE14 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10719537

Browse the full library · About the Tower of Babel